Company intelligence / Profile preview

Carroucell

Sainte-Hélène-du-Lac, Auvergne-Rhône-Alpes, France

Ownership: Private
Development stage: Other

Overview

Carroucell develops and commercializes a new generation of glass-based, xenofree, customizable microcarriers produced via a patented sol-gel process to improve yield, quality, and cost-effectiveness of adherent cell culture for cell and gene therapy biomanufacturing; its technology has been validated in collaboration with Etablissement Français du Sang (EFS) and is being industrialized toward GMP-scale production[2][3][4].

Modalities: Cell therapyGene therapy
Industry: Chemicals & Materials

Partnerships

Etablissement Français du Sang (EFS)

Beyond the preview

Go deeper on Carroucell.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Carroucell.

Explore the full profile